What is Dorsata?
Founded in 2011, Dorsata operates at the intersection of medical technology and clinical efficiency. The company focuses exclusively on the Ob-Gyn workflow, providing software tools designed to reduce administrative burden and improve patient outcomes. By integrating directly into the clinical environment, Dorsata addresses the unique challenges faced by obstetricians and gynecologists, positioning itself as an essential partner for modern healthcare systems. Its software architecture is built to support evidence-based care, ensuring that practitioners have access to critical data at the point of care, thereby fostering a more cohesive and efficient patient experience.
How much funding has Dorsata raised?
Dorsata has raised a total of $6.3M across 2 funding rounds:
Angel/Seed
$1.1M
Series A
$5.2M
Angel/Seed (2016): $1.1M with participation from Partnership Fund for New York City, 1776 Ventures, and QED Investors
Series A (2020): $5.2M led by LabCorp, Fool Ventures, Gore Range Capital, Women’s Health USA, and QED Investors
Key Investors in Dorsata
LabCorp
Labcorp Holdings Inc. is a global laboratory services leader providing diagnostic and biopharma laboratory services to hospitals, pharmaceutical companies, and healthcare providers to facilitate data-driven medical decisions.
QED Investors
QED Investors is a boutique venture capital firm specializing in early-stage, disruptive financial services and high-growth technology companies across global markets.
1776 Ventures
1776 Ventures is an incubator and investment community focused on providing entrepreneurs with the mentorship, capital, and market access required to scale complex, problem-solving businesses.
What's next for Dorsata?
Looking ahead, the strategic deployment of the $5.2M capital will likely focus on product diversification and market penetration. As the healthcare industry continues to prioritize digital transformation, Dorsata is poised to leverage its specialized domain expertise to capture a larger share of the enterprise market. The company's trajectory suggests a shift toward broader integration capabilities and the potential for expanded service offerings that address the evolving needs of hospital networks and large-scale medical practices. By maintaining its focus on high-impact clinical workflows, Dorsata remains a key player to watch in the ongoing evolution of health informatics.
See full Dorsata company page
